Spectrum Vascular acquired PICC and Midline Product Portfolios from AngioDynamics, Inc. (NasdaqGS:ANGO) for $45 million on February 15, 2024. Under the terms of the asset purchase agreement, the consideration consists of $34.5 million in cash paid at closing, an earnout related to sales of the divested products over the next two years equal to $5.5 million, and a milestone payment of $5 million paid upon final transfer of the manufacturing of the divested products to a third-party manufacturer. The transaction consists of AngioDynamics? PICC, Midline and tip location products. This combined portfolio of products contributed approximately $43.5 million in annual sales during AngioDynamics? fiscal year 2023. UBS Investment Bank is serving as financial advisor, and Cadwalader, Wickersham & Taft is serving as legal advisor to AngioDynamics. Fried Frank is serving as legal advisor to Specturm Vascular.

Spectrum Vascular completed the acquisition of PICC and Midline Product Portfolios from AngioDynamics, Inc. (NasdaqGS:ANGO) on February 15, 2024.